Serological Diagnosis of HIV
Infection
The initial screening of anti-HIV antibodies is
done by an enzyme-linked immunoassay test (EIA) using HIV antigens obtained
either from infected cells or by recombinant technology. Since this is a
screening test, its cut-off (particularly when used to screen blood in blood
banks) is set for maximal sensitivity, since it is preferable to discard some
blood units that test false positive than to transfuse contaminated units with
low antibody titers that es-cape detection.
Any positive result on ELISA needs to be
confirmed, first by repeating the EIA to rule out errors or technical problems.
If the repeat test is positive, the result should be con-firmed primarily by
Western blot (immunoblot). A Western blot is considered positive if antibodies
to structural proteins (e.g., p24), enzymes (gp41), and envelope glycoproteins
(gp41 or gp120) are simultaneously detected. The accuracy of the combined tests
(EIA and Western blot) is better than 99.5%.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2024 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.